The 15th International Oncolytic Virotherapy Conference took place in Banff, Alberta, and showcased diverse new approaches to enhancing oncolytic virus therapy. A reflective keynote highlighted industry challenges and lessons. Presentations covered preclinical advancements, combination therapies, mechanisms and biomarkers, and many examples of clinical efficacy against various cancers. The 15th International Oncolytic Virotherapy Conference took place in Banff, Alberta, and showcased diverse new approaches to enhancing oncolytic virus therapy. A reflective keynote highlighted industry challenges and lessons. Presentations covered preclinical advancements, combination therapies, mechanisms and biomarkers, and many examples of clinical efficacy against various cancers.
No takes yet. Share an insight, caveat, or question.
Rajwani et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: